243 related articles for article (PubMed ID: 26658871)
21. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.
Young ML; Franklin JL
Mol Cell Neurosci; 2019 Dec; 101():103409. PubMed ID: 31521745
[TBL] [Abstract][Full Text] [Related]
22. Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome.
Berg EL; Pride MC; Petkova SP; Lee RD; Copping NA; Shen Y; Adhikari A; Fenton TA; Pedersen LR; Noakes LS; Nieman BJ; Lerch JP; Harris S; Born HA; Peters MM; Deng P; Cameron DL; Fink KD; Beitnere U; O'Geen H; Anderson AE; Dindot SV; Nash KR; Weeber EJ; Wöhr M; Ellegood J; Segal DJ; Silverman JL
Transl Psychiatry; 2020 Jan; 10(1):39. PubMed ID: 32066685
[TBL] [Abstract][Full Text] [Related]
23. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Zhao W; Xu Z; Cao J; Fu Q; Wu Y; Zhang X; Long Y; Zhang X; Yang Y; Li Y; Mi W
J Neuroinflammation; 2019 Nov; 16(1):230. PubMed ID: 31747905
[TBL] [Abstract][Full Text] [Related]
24. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
[TBL] [Abstract][Full Text] [Related]
25. PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome.
Sun J; Liu Y; Zhu G; Cato C; Hao X; Qian L; Lin W; Adhikari R; Luo Y; Baudry M; Bi X
Sci Rep; 2020 Jun; 10(1):9824. PubMed ID: 32555345
[TBL] [Abstract][Full Text] [Related]
26. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.
Rodriguez-Cuenca S; Cochemé HM; Logan A; Abakumova I; Prime TA; Rose C; Vidal-Puig A; Smith AC; Rubinsztein DC; Fearnley IM; Jones BA; Pope S; Heales SJ; Lam BY; Neogi SG; McFarlane I; James AM; Smith RA; Murphy MP
Free Radic Biol Med; 2010 Jan; 48(1):161-72. PubMed ID: 19854266
[TBL] [Abstract][Full Text] [Related]
27. Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model.
Filonova I; Trotter JH; Banko JL; Weeber EJ
Learn Mem; 2014 Jan; 21(2):98-104. PubMed ID: 24434871
[TBL] [Abstract][Full Text] [Related]
28. Characterizing spine issues: If offers novel therapeutics to Angelman syndrome.
Yang X
Dev Neurobiol; 2020 May; 80(5-6):200-209. PubMed ID: 32378784
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
[TBL] [Abstract][Full Text] [Related]
30. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
31. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
32. Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome.
Riday TT; Dankoski EC; Krouse MC; Fish EW; Walsh PL; Han JE; Hodge CW; Wightman RM; Philpot BD; Malanga CJ
J Clin Invest; 2012 Dec; 122(12):4544-54. PubMed ID: 23143301
[TBL] [Abstract][Full Text] [Related]
33. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
34. Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.
Pastuzyn ED; Shepherd JD
Front Mol Neurosci; 2017; 10():234. PubMed ID: 28804447
[TBL] [Abstract][Full Text] [Related]
35. Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease.
Park SY; Pekas EJ; Headid RJ; Son WM; Wooden TK; Song J; Layec G; Yadav SK; Mishra PK; Pipinos II
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H456-H467. PubMed ID: 32706261
[TBL] [Abstract][Full Text] [Related]
36. Recovery of Angelman syndrome rat deficits with UBE3A protein supplementation.
Dodge A; Morrill NK; Weeber EJ; Nash KR
Mol Cell Neurosci; 2022 May; 120():103724. PubMed ID: 35367589
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
[TBL] [Abstract][Full Text] [Related]
38. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons.
Albrecht U; Sutcliffe JS; Cattanach BM; Beechey CV; Armstrong D; Eichele G; Beaudet AL
Nat Genet; 1997 Sep; 17(1):75-8. PubMed ID: 9288101
[TBL] [Abstract][Full Text] [Related]
39. α1-Na/K-ATPase inhibition rescues aberrant dendritic calcium dynamics and memory deficits in the hippocampus of an Angelman syndrome mouse model.
Rayi PR; Koyavski L; Chakraborty D; Bagrov A; Kaphzan H
Prog Neurobiol; 2019 Nov; 182():101676. PubMed ID: 31401139
[TBL] [Abstract][Full Text] [Related]
40. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.
Pignatelli M; Piccinin S; Molinaro G; Di Menna L; Riozzi B; Cannella M; Motolese M; Vetere G; Catania MV; Battaglia G; Nicoletti F; Nisticò R; Bruno V
J Neurosci; 2014 Mar; 34(13):4558-66. PubMed ID: 24672001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
